Explorez tous les épisodes du podcast Keeping Current
| Titre | Date | Durée | |
|---|---|---|---|
| The Rise of the Machines: A Quickfire Exploration of Artificial Intelligence and Big Data in Oncology | 09 Sep 2024 | 00:17:51 | |
Did you know that artificial intelligence (AI) is shaping the future of oncology? Our expert faculty discuss in this rapid question and answer program! Credit available for this activity expires: 9/6/25 | |||
| Chikungunya Virus Vaccine: A New Addition to the Travel Vaccine Armamentarium | 29 Aug 2024 | 00:31:22 | |
Do you know how to identify individuals at risk for chikungunya virus-related disease who may benefit from vaccination? Credit available for this activity expires: 8/29/2025 | |||
| Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today | 17 Jul 2024 | 00:29:49 | |
Clinical trials have reshaped multidisciplinary treatment paradigms for early-stage disease. Is your clinic up to date? Credit available for this activity expires: 7/15/25 | |||
| Impact of Nutritional Management for Cow’s Milk Allergy: Can It Interrupt the Allergic March? | 23 Jun 2023 | 00:34:19 | |
Did you know that early-life cow’s milk allergy could be one of the first stages of the atopic march? Credit available for this activity expires: 6/22/24 | |||
| Long-Term Management of Reflux and Deprescribing PPI Therapy: Expert Perspectives | 22 Jun 2023 | 00:32:10 | |
Did you know that many people taking proton pump inhibitors (PPIs) do not have a formal indication for them? Credit available for this activity expires: 6/22/24 | |||
| Dengue: Vaccinating Travelers to Endemic Regions | 19 Jun 2023 | 00:16:24 | |
Find out how travelers can protect themselves from dengue. Credit available for this activity expires: 6/16/24 | |||
| A Patient With Type 2 Diabetes and Chronic Kidney Disease in Clinical Practice | 16 Jun 2023 | 00:21:30 | |
What do you do when your patient with type 2 diabetes (T2D) has a change in kidney function? Credit available for this activity expires: 6/15/24 | |||
| Demystifying the Science of New Anti-Seizure Medications and Application to Clinical Practice | 16 Jun 2023 | 00:29:56 | |
Accept the challenge to be more ambitious for patients by learning how to navigate the complexity of anti-seizure medications. | |||
| Development of Heart Failure Following Myocardial Infarction: Why Risks Still Remain High | 15 Jun 2023 | 00:20:08 | |
Did you know that 1 in 5 patients develop heart failure within 5 years following myocardial infarction? | |||
| Expert Exchange: Clinical Implications of the Latest Advances in Metastatic Breast Cancer | 14 Jun 2023 | 00:34:33 | |
Do you know how to personalize treatment for your patients with metastatic breast cancer (mBC)? How can you incorporate emerging treatment strategies? Credit available for this activity expires: 6/12/24 | |||
| Meeting the Experts and Taking Action in Heart Failure | 14 Jun 2023 | 00:22:33 | |
Credit available for this activity expires: 6/13/24 | |||
| Classification and Nomenclature of IC-MPGN and C3G: A Spectrum of Diseases or Distinct Entities? | 09 Jun 2023 | 00:23:25 | |
Discover expert tips from Dr Kavanagh on how to appropriately classify patients with C3G and IC-MPGN. | |||
| Adherence to Lipid-Lowering Therapies: How Can We Tackle This Barrier Better? | 06 Jun 2023 | 00:38:07 | |
How can you help improve medication adherence? Drs Sabatine, Bosworth, and Tokgozoglu discuss. Credit available for this activity expires: 6/5/24
| |||
| Exploring the Value of Delivering Lung Cancer Medicines in Different Ways: Optimizing the Patient Experience | 12 Jul 2024 | 00:41:57 | |
New subcutaneous (SC) therapies are becoming available in lung cancer. Are you ready to talk to your patients about these? Credit available for this activity expires: 7/10/25 | |||
| A Patient Is Waiting for a Liver Transplant: What Can We Do Now and What Could We Have Done Better? | 31 May 2023 | 00:27:20 | |
Did you know that between 5% to 13% of patients with Wilson disease are liver transplanted? Credit available for this activity expires: 5/31/24 | |||
| Reducing the Risks of Hyperkalemia in the Treatment of Heart Failure and Chronic Kidney Disease: What It Means for Management Teams | 31 May 2023 | 00:42:38 | |
Did you know that up to 47% of patients taking renin-angiotensin-aldosterone system inhibitors see their therapy discontinued after developing mild or moderate-to-severe hyperkalemia? Credit available for this activity expires: 5/31/24 | |||
| Dengue Prevention: Integrating Vaccination Into Comprehensive Control Strategies Across Populations | 22 May 2023 | 00:38:19 | |
Do you know the priorities for implementing a successful dengue vaccination strategy? Credit available for this activity expires: 5/19/24 | |||
| Early-Stage Resectable Non-Small Cell Lung Cancer: Sharing Patient Perspectives | 08 May 2023 | 00:35:18 | |
The complexity of treatment has increased dramatically; how effectively are you communicating with your patients? | |||
| Gaining Control With Early Combination Lipid-Lowering Therapy: Applying Learnings From the Queen's Gambit | 03 May 2023 | 00:36:29 | |
Is initial combination lipid-lowering therapy really necessary? Expert faculty discuss. Credit available for this activity expires: 05/02/24 | |||
| Looking Forward to Thriving With HIV: Interventions to Improve and Maintain Health in People With HIV | 01 May 2023 | 00:33:00 | |
Did you know that kindness in the clinic can improve antiretroviral therapy adherence? | |||
| Three Cardiovascular Risk Cases: Why and Who Should We Be Testing for Lp(a) | 18 Apr 2023 | 00:41:14 | |
When to measure lipoprotein (Lp)(a) and what to do with it? Drs Ray and Kronenberg discuss. | |||
| Well Begun Is Half Done: Why and How Do We Assess Activity of the Complement Pathway in the Clinic? | 14 Apr 2023 | 00:37:42 | |
Do you want to gain expert insights on the role of kidney biopsy and complement assays for complement-mediated kidney diseases? | |||
| What’s New in Diabetic Eye Disease Technologies | 31 Mar 2023 | 00:35:08 | |
Half of people with severe non-proliferative diabetic retinopathy will have proliferative disease within a year. What can be done? | |||
| Biosimilars in Multiple Sclerosis: Entering a New Era of Biologic Therapy | 30 Mar 2023 | 00:37:54 | |
Did you know what the inherent variability of all biologics and what degree of variation are acceptable by regulatory bodies? Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/989395?src=mkm_podcast_addon_989395
| |||
| Latest Advances in Breast Cancer Care: Highlights From Chicago 2024 | 11 Jul 2024 | 00:16:37 | |
Missed the last oncology meeting in Chicago or simply want to recap the highlights? This rapid-fire program was made for you! Credit available for this activity expires: 7/9/25 | |||
| Are We Ready for Biosimilars in Multiple Sclerosis? Experts Discuss Lessons From Other Immune-Mediated Diseases | 29 Mar 2023 | 00:34:40 | |
What is the clinical use of biosimilars and how to best communicate with patients to avoid the nocebo effect? Credit available for this activity expires: 3/29/24 | |||
| Global Perspectives on Anti-Vascular Endothelial Growth Factor: If, When, and How to Switch | 29 Mar 2023 | 01:01:13 | |
Do you reload when switching? What intervals do you extend by? How long is feasible between treatments, and how do you monitor? Learn from the experts. | |||
| Clinical Trials in Focus: Durability of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies | 28 Mar 2023 | 00:34:58 | |
Do you know how study designs influence the data with anti-vascular endothelial growth factor (anti-VEGF) therapies? Find out more. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[ArticleID]?src=mkm_podcast_addon_989801
| |||
| Safeguarding the CKD Patient With or Without Diabetes in Primary Care: Quick Questions, Rapid Replies | 27 Mar 2023 | 00:17:52 | |
Did you know that SGLT2 blockade can reduce progression to ESKD by at least a decade in patients with mild-to-moderately decreased eGFR? Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990093?ecd=bdc_podcast_libsyn_mscpedu | |||
| Optimizing Treatments in Advanced Systemic Mastocytosis With Associated Hematological Neoplasm | 27 Mar 2023 | 00:36:36 | |
Do you know which you should be treating first -- the systemic mastocytosis (SM) or the associated hematological neoplasm (AHN)? | |||
| Diabetes Dialogue Part 2: Who Are Candidates for GLP-1 Receptor Agonist Therapy in Primary Care? | 24 Mar 2023 | 00:18:54 | |
Who should be taking a glucagon-like peptide-1 (GLP-1) receptor agonist (RA)? Join Drs Bain and Lin to find out. Credit available for this activity expires: 3/23/24 | |||
| Challenging the Harmful Myths About ASCVD Management: The Experts Set the Record Straight | 23 Mar 2023 | 00:21:10 | |
Do you know the latest information about dyslipidemia and atherosclerotic cardiovascular disease (ASCVD) risk? Drs Navar and Ray discuss. | |||
| What Is the Expert Accord on Identifying and Protecting the Patient at Early Stage of CKD? | 16 Mar 2023 | 00:37:04 | |
Did you know that early diabetic kidney disease may reduce the life expectancy of patients by 16 years? Credit available for this activity expires: 3/14/24 | |||
| Optimizing Adjuvant Treatment of Early Breast Cancer: Where Are We Today? | 16 Mar 2023 | 00:27:11 | |
PARP inhibitors, CDK4/6 inhibitors, immunotherapy, and SERDS: Can you select optimal treatments for early breast cancer (EBC)? And what might be the consensus at St. Gallen? | |||
| Pros and Cons of COVID-19 Vaccination in Children: Weighing the Evidence | 02 Mar 2023 | 00:38:10 | |
Are you up to date on COVID-19 vaccination in children?
| |||
| Obesity Care: Improving Health Outcomes in Collaboration With the Patient | 28 Jun 2024 | 00:35:14 | |
What impact can weight loss have on the lives of your patients living with obesity? What treatment options are available to help you help them? | |||
| The Road to Safety: Understanding the Common and Less Common Side Effects of COVID-19 and Other Vaccines | 28 Feb 2023 | 00:38:34 | |
Do you know what are common and less common adverse events (AEs) following immunization? Credit available for this activity expires: 02/27/24 | |||
| Recovering Immune Responses in Heavily Treatment-Experienced HIV-Positive Individuals | 14 Feb 2023 | 00:16:42 | |
This educational activity is intended for an international audience of non-US HIV physicians, infectious disease (ID) physicians, and primary care providers (PCPs). Credit available for this activity expires: 2/13/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987954?src=mkm_podcast_addon_987954 | |||
| COVID-19 Immunization in Oncology and Stem Cell Transplant Settings: Experts Provide Practical Guidance | 13 Feb 2023 | 00:33:06 | |
Did you know that many patients with malignancy have insufficient benefit from 2 doses of COVID-19 vaccines? Join this discussion and see how their outcomes can be improved. Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987844?src=mkm_podcast_addon_987844 | |||
| Chronic Kidney Disease – Looking Beyond Diabetes: Expert Interpretation of Latest Evidence From Kidney Outcome Trials | 08 Feb 2023 | 00:15:48 | |
How often should you be monitoring kidney function in a patient with an estimated glomerular filtration rate (eGFR) of 50 mL/min/1.73 m2 and a urine albumin-to-creatinine ratio (UACR) above 30 mg/g? Credit available for this activity expires: 2/7/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987836?src=mkm_podcast_addon_987836
| |||
| Dengue Immunization: Special Populations | 03 Feb 2023 | 00:33:10 | |
Do you know how dengue vaccines can protect special populations and be used during outbreaks? Credit available for this activity expires: 02/01/24 | |||
| Evolving Hesitancies and Objections to COVID-19 Booster Shots: Separating Facts From Fiction | 31 Jan 2023 | 00:40:36 | |
Are you prepared to address your patients’ hesitancy and misinformation about COVID-19 booster shots? | |||
| Recent Updates in HR-Positive/HER2-Negative Early Breast Cancer: A Deep Dive Into Understanding the Data and Their Implications | 31 Jan 2023 | 00:33:11 | |
Will the newly reported monarchE data change your clinical practice for patients with HR+/HER- early breast cancer? Credit available for this activity expires: 1/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987087?src=mkm_podcast_addon_987087 | |||
| Early-Stage Resectable Non-Small Cell Lung Cancer: Navigating a Changing Treatment Landscape | 26 Jan 2023 | 00:36:16 | |
Did you know that there are now promising perioperative immunotherapies available for your patients with early-stage NSCLC?
| |||
| Advanced Age-Related Macular Degeneration: How to Use Imaging to Screen and Monitor Patients | 23 Jan 2023 | 00:34:17 | |
A quarter of people aged over 60 have early or intermediate age-related macular degeneration (AMD). Do you know how to assess these patients and determine follow-up schedules? Credit available for this activity expires: 01/19/24 | |||
| Insights and Understanding of the Impact of Inflammation in HIV-Positive Individuals | 23 Jan 2023 | 00:30:14 | |
Do you know what the consequences of chronic immune activation are for your patients living with HIV? Credit available for this activity expires: 01/18/24 | |||
| The Evolution of Incretins – A Revolution in Diabetes Management? | 27 Jun 2024 | 00:35:55 | |
The expanding world of glucagon-like peptide-1 (GLP-1) receptor antagonism. What do these developments mean for clinical practice? Credit available for this activity expires: 6/27/25 | |||
| Ideal Dengue Vaccine Characteristics | 10 Jan 2023 | 00:16:34 | |
Did you know that a new dengue vaccine has been approved by the European Medicines Agency? Credit available for this activity expires: 01/09/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/986481?ecd=bdc_podcast_libsyn_mscpedu | |||
| Spotlight on Chronic Lymphocytic Leukemia: Exploring the Continued Evolution of Bruton Tyrosine Kinase Inhibitors for Our Patients | 04 Jan 2023 | 00:28:56 | |
Did you know there are 3 Bruton tyrosine kinase (BTK) inhibitors approved to treat chronic lymphocytic leukemia (CLL) in Europe? Credit available for this activity expires: 1/4/2024 | |||
| Where Are We Now in the Use of Interleukin-17 Inhibitors for Psoriatic Disease? | 04 Jan 2023 | 00:39:17 | |
Can you navigate the increasingly complex treatment landscape for psoriasis and psoriatic arthritis (PsA)? Earn Credit / Learning Objectives & Disclosures: | |||